Skip to main content
    A

    Anika Therapeutics Inc (ANIK)

    Official site

    HEALTHCARE • DRUG MANUFACTURERS - SPECIALTY & GENERIC • NASDAQ

    $12.92
    -0.48 (-3.58%)

    Market Cap: $179.50M

    Last updated: Nov 17, 2026 at 11:04 AM ET

    Anika Therapeutics Inc (ANIK) Competitors

    Updated Nov 17, 2026. Similar companies are ranked by business profile, size, sector and industry; metrics come from company filings and market prices.

    The companies most similar to Anika Therapeutics are Akebia Ther (AKBA), Journey Medical (DERM) and Cardiol Therapeutics (CRDL). By market cap, Anika Therapeutics ranks 7th of the 13 companies on this page; Alpha Teknova (TKNO) is the largest at $516.43M.

    Peer Comparison

    ANIK's revenue growth of 10.0% is above the peer median of -27.9%. Like the median peer, it pays no dividend.

    CompanyMarket capP/EP/SNet marginROICRev growthDiv yield
    Anika Therapeutics (ANIK)$179.50M18.7x1.4x-1.4%N/A10.0%0.00%
    Akebia Ther (AKBA)$131.67MN/A0.6x-22.6%-38.9%-37.2%0.00%
    Journey Medical Corp (DERM)$122.24MN/A1.5x-7.3%-2.8%7.6%0.00%
    Cardiol Therapeutics Inc Class A (CRDL)$127.69MN/AN/A0.0%N/A0.0%0.00%
    SIGA Technologies Inc (SIGA)$196.88M475.0xN/A1.3%N/A-49.7%0.00%
    BioAge Labs, Inc (BIOA)$255.03MN/A27.9x0.0%N/A-85.5%0.00%
    Lifecore Biomedical Inc. (LFCR)$243.36MN/AN/A-66.8%N/A-18.6%0.00%
    Organogenesis Holdings Inc (ORGO)$105.15MN/A0.3x-38.5%-66.3%-69.9%0.00%
    Cumberland Pharmaceuticals Inc (CPIX)$88.16MN/A3.1x148.6%N/A-74.0%28.79%
    OrganiGram Holdings Inc (OGI)$116.93MN/A0.4x28.0%-1.2%49.4%0.00%
    Tilray Inc (TLRY)$359.12MN/A0.3x-17.1%-4.9%22.7%0.00%
    Alpha Teknova Inc (TKNO)$516.43MN/A9.1x-34.8%-20.5%21.5%0.00%
    Emergent Biosolutions Inc (EBS)$297.69MN/A0.5x-40.2%-20.5%-52.4%0.00%
    Peer median$164.28M475.0x0.6x-12.2%-20.5%-27.9%0.00%
    Market data as of Nov 17, 2026. Net margin covers the trailing 12 months, Rev growth compares the latest quarter with a year earlier and Div yield is the forward yield. P/E uses earnings per share for the last 12 months as companies report it, often adjusted, so it can show beside a negative net margin, which uses net income. P/E and P/S show N/A when those earnings or sales are negative or missing, or the multiple is above 1,000x.

    Similar Companies

    These are the 12 companies most similar to Anika Therapeutics, ranked by how closely their business, size, sector and industry match. All 12 are in one industry, Drug Manufacturers - Specialty & Generic.

    CompanyAboutPeers
    Akebia Ther (AKBA)
    Akebia Therapeutics, Inc., a biopharmaceutical company, focuses on the development and commercialization of kidney therapies for patients with kidney disease.
    AKBA competitors
    Journey Medical Corp (DERM)
    Dermira, Inc., a biopharmaceutical company, develops and markets therapies for patients with dermatological diseases in the United States.
    DERM competitors
    Cardiol Therapeutics Inc Class A (CRDL)
    Cardiol Therapeutics Inc., a clinical-phase biotechnology company, focuses on the research and development of anti-inflammatory therapies for the treatment...
    CRDL competitors
    SIGA Technologies Inc (SIGA)
    SIGA Technologies, Inc., a commercial-stage pharmaceutical company, focuses on the health safety and infectious disease markets in the United States.
    SIGA competitors
    BioAge Labs, Inc (BIOA)
    BioAmber Inc., an industrial biotechnology company, produces and sells bio-succinic acid to various customers in the chemical market primarily in the United...
    BIOA competitors
    Lifecore Biomedical Inc. (LFCR)
    Lifecore Biomedical, Inc., is an integrated contract development and manufacturing organization in the United States and internationally.
    LFCR competitors
    Organogenesis Holdings Inc (ORGO)
    Organogenesis Holdings Inc., a regenerative medicine company, develops, manufactures and markets solutions for the advanced wound care and surgical and sports...
    ORGO competitors
    Cumberland Pharmaceuticals Inc (CPIX)
    Cumberland Pharmaceuticals Inc., a specialty pharmaceutical company, focuses on the acquisition, development...
    CPIX competitors
    OrganiGram Holdings Inc (OGI)
    Organigram Holdings Inc. produces and sells cannabis and cannabis-derived products in Canada. The company is headquartered in Moncton, Canada.
    OGI competitors
    Tilray Inc (TLRY)
    Tilray Inc. is dedicated to the research, cultivation, production and distribution of medicinal cannabis and cannabinoids.
    TLRY competitors
    Alpha Teknova Inc (TKNO)
    Alpha Teknova Inc (TKNO) is a leading entity in the synthetic biology industry, specializing in the development of essential biological reagents and supplements...
    TKNO competitors
    Emergent Biosolutions Inc (EBS)
    Emergent BioSolutions Inc., a life sciences company, focuses on providing preparedness and response products and solutions for civilian and military populations...
    EBS competitors

    Frequently Asked Questions About ANIK

    Who are Anika Therapeutics' main competitors?

    The companies most similar to Anika Therapeutics include Akebia Ther (AKBA), Journey Medical (DERM), Cardiol Therapeutics (CRDL), SIGA Technologies (SIGA) and BioAge Labs (BIOA), listed from the closest match.

    Who is Anika Therapeutics' biggest competitor?

    Alpha Teknova (TKNO) is the largest of the similar companies at $516.43M; Akebia Ther (AKBA) is the closest match by business profile, size, sector and industry.

    How does ANIK stock compare with its competitors?

    ANIK's P/E is 18.7x against a peer median of 475.0x; its P/S is 1.4x against a peer median of 0.6x; its net margin is -1.4% against a peer median of -12.2%.

    Which of Anika Therapeutics' competitors pays a higher dividend?

    Anika Therapeutics pays no dividend. Cumberland Pharmaceuticals (CPIX) has a higher forward dividend yield; Cumberland Pharmaceuticals (CPIX) has the highest at 28.79%.

    Is Anika Therapeutics bigger than its competitors?

    No. Anika Therapeutics is 7th by market cap among the 13 companies on this page; the largest is Alpha Teknova (TKNO) at $516.43M.